Insmed Incorporated Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2025: USD -798.08 M

Insmed Incorporated Net Cash Used For Investing Activities is USD -798.08 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -2,750.12% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Insmed Incorporated Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 30.11 M, a -72.23% change year over year.
  • Insmed Incorporated Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 108.42 M, a -165.91% change year over year.
  • Insmed Incorporated Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -164.51 M, a 2,989.99% change year over year.
  • Insmed Incorporated Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -5.32 M, a -86.99% change year over year.
Key Data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Depreciation And Amortization Dividends Paid